Evaluation of the Safety, Tolerability and Immunogenicity of VARIVAX ™ in Healthy Russians (V210-058)

Condition:   Varicella Intervention:   Biological: VARIVAX™ Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials